Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging.

Nye JA, Purselle D, Plisson C, Voll RJ, Stehouwer JS, Votaw JR, Kilts CD, Goodman MM, Nemeroff CB.

Depress Anxiety. 2013 Oct;30(10):902-7. doi: 10.1002/da.22049. Epub 2013 Mar 22.

PMID:
23526784
2.

Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.

Yeh YW, Ho PS, Chen CY, Kuo SC, Liang CS, Ma KH, Shiue CY, Huang WS, Cheng CY, Wang TY, Lu RB, Huang SY.

Int J Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu065. doi: 10.1093/ijnp/pyu065.

3.

Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder.

Miller JM, Hesselgrave N, Ogden RT, Sullivan GM, Oquendo MA, Mann JJ, Parsey RV.

Biol Psychiatry. 2013 Aug 15;74(4):287-95. doi: 10.1016/j.biopsych.2013.01.024. Epub 2013 Mar 1.

4.

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.

Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, Manji HK, Drevets WC.

Biol Psychiatry. 2007 Oct 15;62(8):870-7. Epub 2007 Aug 2.

PMID:
17678634
5.

Structural and functional neuroimaging studies of the suicidal brain.

Desmyter S, van Heeringen C, Audenaert K.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):796-808. doi: 10.1016/j.pnpbp.2010.12.026. Epub 2011 Jan 6. Review.

PMID:
21216267
6.

Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.

Hahn A, Haeusler D, Kraus C, Höflich AS, Kranz GS, Baldinger P, Savli M, Mitterhauser M, Wadsak W, Karanikas G, Kasper S, Lanzenberger R.

Hum Brain Mapp. 2014 Aug;35(8):3857-66. doi: 10.1002/hbm.22442. Epub 2014 Jan 17.

PMID:
24443158
7.

Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: An ultra-high resolution PET-MRI study.

Kim JH, Son YD, Kim JH, Choi EJ, Lee SY, Joo YH, Kim YB, Cho ZH.

Brain Res. 2015 Dec 10;1629:63-71. doi: 10.1016/j.brainres.2015.10.006. Epub 2015 Oct 13.

PMID:
26459992
8.

Lower serotonin transporter binding potential in the human brain during major depressive episodes.

Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ.

Am J Psychiatry. 2006 Jan;163(1):52-8.

PMID:
16390889
9.

Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.

Yeh YW, Ho PS, Kuo SC, Chen CY, Liang CS, Yen CH, Huang CC, Ma KH, Shiue CY, Huang WS, Shyu JF, Wan FJ, Lu RB, Huang SY.

Int J Neuropsychopharmacol. 2015 Jan 7;18(7):pyu120. doi: 10.1093/ijnp/pyu120.

10.

Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.

Kim JH, Son YD, Kim JH, Choi EJ, Lee SY, Lee JE, Cho ZH, Kim YB.

Psychiatry Res. 2015 Jan 30;231(1):50-7. doi: 10.1016/j.pscychresns.2014.10.022. Epub 2014 Nov 5.

PMID:
25465315
11.

Suicidal ideation modulates the reduction in serotonin transporter availability in male military conscripts with major depression: A 4-[18F]-ADAM PET study.

Yeh YW, Ho PS, Chen CY, Kuo SC, Liang CS, Yen CH, Huang CC, Shiue CY, Huang WS, Ma KH, Lu RB, Huang SY.

World J Biol Psychiatry. 2015 Oct;16(7):502-12. doi: 10.3109/15622975.2015.1048722. Epub 2015 Jun 12.

PMID:
26068129
12.

Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.

Lanzenberger R, Kranz GS, Haeusler D, Akimova E, Savli M, Hahn A, Mitterhauser M, Spindelegger C, Philippe C, Fink M, Wadsak W, Karanikas G, Kasper S.

Neuroimage. 2012 Nov 1;63(2):874-81. doi: 10.1016/j.neuroimage.2012.07.023. Epub 2012 Jul 22.

PMID:
22828162
13.

Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.

Miller JM, Everett BA, Oquendo MA, Ogden RT, Mann JJ, Parsey RV.

Synapse. 2016 Jan;70(1):24-32. doi: 10.1002/syn.21868. Epub 2015 Oct 19.

14.

Regional brain glucose uptake distinguishes suicide attempters from non-attempters in major depression.

Sublette ME, Milak MS, Galfalvy HC, Oquendo MA, Malone KM, Mann JJ.

Arch Suicide Res. 2013;17(4):434-47. doi: 10.1080/13811118.2013.801813.

15.

Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.

Kim E, Howes OD, Park JW, Kim SN, Shin SA, Kim BH, Turkheimer FE, Lee YS, Kwon JS.

Psychol Med. 2016 Jan;46(2):357-66. doi: 10.1017/S0033291715001865. Epub 2015 Oct 1.

PMID:
26423910
16.

Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.

Sullivan GM, Oquendo MA, Milak M, Miller JM, Burke A, Ogden RT, Parsey RV, Mann JJ.

JAMA Psychiatry. 2015 Feb;72(2):169-78. doi: 10.1001/jamapsychiatry.2014.2406.

17.

5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.

Bhagwagar Z, Murthy N, Selvaraj S, Hinz R, Taylor M, Fancy S, Grasby P, Cowen P.

Am J Psychiatry. 2007 Dec;164(12):1858-65.

PMID:
18056241
18.

Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT.

Schain M, Tóth M, Cselényi Z, Arakawa R, Halldin C, Farde L, Varrone A.

Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):228-37. doi: 10.1007/s00259-012-2260-3. Epub 2012 Oct 18.

PMID:
23076621
19.

123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.

Newberg AB, Amsterdam JD, Wintering N, Ploessl K, Swanson RL, Shults J, Alavi A.

J Nucl Med. 2005 Jun;46(6):973-7.

20.

Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior.

Oquendo MA, Galfalvy H, Sullivan GM, Miller JM, Milak MM, Sublette ME, Cisneros-Trujillo S, Burke AK, Parsey RV, Mann JJ.

JAMA Psychiatry. 2016 Oct 1;73(10):1048-1055. doi: 10.1001/jamapsychiatry.2016.1478.

PMID:
27463606

Supplemental Content

Support Center